Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Kissei licenses antidiabetic agent to Purdue

May 8, 1997

Genentech enters into agreement for embryonic stem cell renewal factor

May 8, 1997

Senetek seeks European approval of erectile dysfunction therapy

May 8, 1997

DEA recommends descheduling of Redux

May 7, 1997

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

Gene Logic and Johns Hopkins University enter into research collaboration

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

Positive clinical results for amylin analogue in diabetes

May 7, 1997

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

May 7, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.